Recent Posts
- Naveris Announces Launch of Phase II Clinical Study in MRD+ Head and Neck Cancer
- Naveris Awarded ADLT Status by CMS for the NavDx® Test
- Naveris Announces New Data at EUROGIN International Multidisciplinary HPV Congress 2024
- Naveris Unveils NAVigate-HPV: A Groundbreaking Registry to Advance HPV-Driven Cancer Diagnosis and Treatment
- Naveris Announces New Data at ASTRO Multidisciplinary Head and Neck Cancers Symposium 2024
Recent Comments